Shares of Bausch Health Cos Inc. (NYSE:BHC - Get Free Report) fell 2.9% during trading on Monday . The company traded as low as $5.72 and last traded at $5.81. 705,733 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 2,604,550 shares. The stock had previously closed at $5.98.
Analysts Set New Price Targets
BHC has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Bausch Health Cos from a "buy" rating to a "hold" rating in a research report on Saturday, May 10th. Royal Bank Of Canada boosted their target price on shares of Bausch Health Cos from $8.50 to $10.00 and gave the stock a "sector perform" rating in a research report on Friday, May 2nd. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the stock. Based on data from MarketBeat, Bausch Health Cos has a consensus rating of "Hold" and an average target price of $7.42.
View Our Latest Research Report on BHC
Bausch Health Cos Trading Up 8.1%
The company's 50-day moving average price is $4.94 and its two-hundred day moving average price is $6.37. The company has a market cap of $2.29 billion, a P/E ratio of -56.30 and a beta of 0.28.
Insider Activity at Bausch Health Cos
In other news, Director John Paulson bought 754,134 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was purchased at an average price of $5.05 per share, for a total transaction of $3,808,376.70. Following the transaction, the director now owns 27,193,169 shares in the company, valued at approximately $137,325,503.45. This trade represents a 2.85% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders acquired a total of 6,352,667 shares of company stock valued at $35,870,767 in the last quarter. Insiders own 8.05% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Cary Street Partners Financial LLC bought a new position in Bausch Health Cos in the 1st quarter worth about $27,000. Caitong International Asset Management Co. Ltd bought a new position in Bausch Health Cos in the 1st quarter worth about $27,000. SBI Securities Co. Ltd. grew its position in Bausch Health Cos by 244.2% in the 1st quarter. SBI Securities Co. Ltd. now owns 4,230 shares of the company's stock worth $27,000 after purchasing an additional 3,001 shares during the last quarter. Mountain Hill Investment Partners Corp. bought a new position in Bausch Health Cos in the 4th quarter worth about $56,000. Finally, Wealthquest Corp bought a new position in Bausch Health Cos in the 1st quarter worth about $58,000. Institutional investors own 78.65% of the company's stock.
Bausch Health Cos Company Profile
(
Get Free Report)
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Read More
Before you consider Bausch Health Cos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Cos wasn't on the list.
While Bausch Health Cos currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.